Four decades into the nation’s ‘war on cancer,’ the Wilmot Cancer Institute and its director Jonathan Friedberg prepare for the next era in the fight.
Music is an approachable way for patients to express the emotional challenges that accompany a cancer diagnosis and treatment, said panelist Rosemary Obi, a licensed music therapist at Golisano Children’s Hospital.
Brain biologist Michelle Janelsins is a recipient of the five-year NIH grant as a winner of the 2014 NIH Directors New Innovators Award. She is one of 49 young research scientists nationally to win the prize.
The National Cancer Institute grant, award to Principal Investigator Gary R. Morrow, funds a leadership role in a nationwide clinical research network to investigate cancer-related side effects.
The National Cancer Institute has awarded an $18.5 million grant to the University of Rochester’s Wilmot Cancer Institute, officials said Thursday.
Marked for the institute’s Cancer Control and Survivorship program, the five-year grant will fund a study of cancer-related side effects.
Biologists Vera Gorbunova and Andei Seluanov have discovered one reason for the the increase in DNA damage as we age: the primary repair process begins to fail and is replaced by one that is less accurate.
The University of Rochester has received $3.7 million in federal funding to conduct clinical trials aimed at improving cancer control and protection.
The grant was announced Friday by Sens. Charles Schumer and Kirsten Gillibrand, both D-N.Y. The funding supports the University of Rochester Cancer Center, which has been a part of the National Cancer Institutes Community Clinical Oncology Program.
The University of Rochester has been awarded two grants totaling nearly $4.5 million for cancer and heart research. The university is to get more than $3.7 million to fund cancer research projects through the National Cancer Institute, and $742,413 to further develop treatment of Long QT Syndrome Type 3, a disorder affecting the hearts electrical activity.
Investigation in mice shows that blocking the gene’s most important function can slow the disease and extend survival.